Siga Technologies SIGA
NASDAQ SIGA
$2.98 -0.13 (-4.03%)
At close: Aug 20, 2026 · 2:05 PM UTC

Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025)

Siga Technologies' (SIGA) quarterly Income towards Parent Company came in at -$6.4 million in Q3 2025, down 573.67% YoY from $1.3 million in Q3 2024, and down 117.95% on a QoQ basis from $35.5 million in Q2 2025.

Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has 16 years of Income towards Parent Company data on file, last reported at -$6.4 million in Q3 2025.

  • Quarterly Income towards Parent Company fell 573.67% year-over-year to -$6.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 51.44% YoY) and the FY2024 annual result came in at $59.2 million, down 13.01% from the prior year.
  • Income towards Parent Company eased to -$6.4 million in Q3 2025, from $35.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $73.4 million in Q4 2021 to a low of -$6.4 million in Q3 2025.
  • A 5-year average of $13.6 million and a median of -$258928.0 in 2021 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2023 — Income towards Parent Company surged 9000.73% — and 2025, when it sank 573.67%.
  • Tracing SIGA's Income towards Parent Company over 5 years: stood at $73.4 million in 2021, then tumbled by 101.11% to -$811794.0 in 2022, then surged by 9000.73% to $72.3 million in 2023, then sank by 36.67% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
  • The last three Income towards Parent Company figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.87 Bn 42.91 Bn -
2 Teva Pharmaceutical Industries 43.00 Bn 39.35 Bn 2.15 Bn
3 Zoetis 31.59 Bn 29.92 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.15 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn
7 Neurocrine Biosciences 15.55 Bn 15.16 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn -
10 Siga Technologies 213.74 Mn 58.77 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -6.37 Mn
Jun 30, 2025 35.47 Mn
Mar 31, 2025 -370,415.00
Dec 31, 2024 45.76 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 10.28 Mn
Dec 31, 2023 72.26 Mn
Sep 30, 2023 -393,066.00
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -917,677.00
Dec 31, 2022 -811,794.00
Sep 30, 2022 33.04 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -361,049.00
Dec 31, 2021 73.38 Mn
Sep 30, 2021 -3.11 Mn
Jun 30, 2021 -258,928.00
Mar 31, 2021 -1.73 Mn
Dec 31, 2020 20.16 Mn